One-year prognosis of patients with normal myocardial perfusion imaging using technitium-99m sestamibi in suspected coronary artery disease: A single-center experience of 1,047 patients

Perfusion

Volumn 26, Issue 4, 2011, Pages 309-314

  Raziei, Ghasem ^a,b   Tavakoli, Alireza ^a   Asl, Shahram Seifollahi ^a   Amoiei, Mahasti ^a,b   Javadi, Hamid ^c   Assadi, Majid ^d  

^a MILAD HOSPITAL   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiac event; Coronary artery disease (CAD); Normal myocardial perfusion imaging (MPI); Technetium 99m Sestamibi SPECT

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CORONARY ARTERY DISEASE; FEMALE; HEART ARREST; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREADMILL EXERCISE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEATH; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79960106511     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111403027     Document Type: Article

References (22)

1. Amanullah AM. Diagnostic and prognostic value of myocardial perfusion imaging in patients with known or suspected stable coronary artery disease. Echocardiography Aug 2000; 17(6 Pt 1): 587-595.
2. Soman P, Parsons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m Sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol May-Jun 1999; 6(3): 252-256. (Pubitemid 29306433)
3. Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-Sestamibi cardiac imaging. J Nucl Med Apr 1994; 35(4): 554-557. (Pubitemid 24114550)
4. Boyne TS, Koplan BA, Parsons WJ, Smith WH, Watson DD, Beller GA. Predicting adverse outcome with exercise SPECT technetium-99m Sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol Feb 1 1997; 79(3): 270-274. (Pubitemid 27093299)
5. Raiker K, Sinusas AJ, Wackers FJ, Zaret BL. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled Sestamibi exercise imaging. J Nucl Cardiol Sep-Oct 1994; 1(5 Pt 1): 449-456. (Pubitemid 24330041)
6. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation Mar 1 1996; 93(5): 905-914. (Pubitemid 26074827)
7. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand. N Z Med J Jun 28 1996; 109(1024): 224-231.
8. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m Sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol Sep 1995; 26(3): 639-647.
9. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m Sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation Feb 1994; 89(2): 615-622. (Pubitemid 24056187)
10. Travin MI, Duca MD, Kline GM, Herman SD, Demus DD, Heller GV. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m Sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J Jul 1997; 134(1): 73-82. (Pubitemid 27329026)
11. Bodenheimer MM, Wackers FJ, Schwartz RG, Brown M. Prognostic significance of a fixed thallium defect one to six months after onset of acute myocardial infarction or unstable angina. Multicenter Myocardial Ischemia Research Group. Am J Cardiol Dec 15 1994; 74(12): 1196-1200. (Pubitemid 24375007)
12. Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol Nov-Dec 1996; 3(6 Pt 1): 516-537.
13. Bateman TM, Berman DS, Heller GV, et al. American Society of Nuclear Cardiology position statement on electrocardiographic gating of myocardial perfusion SPECT scintigrams. J Nucl Cardiol Jul-Aug 1999; 6(4): 470-471. (Pubitemid 29405970)
14. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stressdobutamine Sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J Oct 1994; 128(4): 713-718.
15. Mandalapu BP, Amato M, Stratmann HG. Technetium Tc 99m Sestamibi myocardial perfusion imaging: current role for evaluation of prognosis. Chest Jun 1999; 115(6): 1684-1694. (Pubitemid 29275665)
16. Chatziioannou SN, Moore WH, Ford PV, et al. Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance. Circulation Feb 23 1999; 99(7): 867-872. (Pubitemid 29094298)
17. Elhendy A, Schinkel A, Bax JJ, van Domburg RT, Poldermans D. Long-term prognosis after a normal exercise stress Tc-99m Sestamibi SPECT study. J Nucl Cardiol May-Jun 2003; 10(3): 261-266. (Pubitemid 36758070)
18. Rozanski A, Gottdiener JS. Stress radionuclide imaging versus stress echocardiography: a framework for comparisons. Prog Cardiovasc Dis Jan-Feb 2001; 43(4): 275-279. (Pubitemid 32158482)
19. Zerahn B, Jensen BV, Nielsen KD, Moller S. Increased prognostic value of combined myocardial perfusion imaging and exercise electrocardiography in patients with coronary artery disease. J Nucl Cardiol Nov-Dec 2000; 7(6): 616-622. (Pubitemid 32042448)
20. Zhang X, Liu X, He ZX, et al. Long-term prognosticvalue of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention. Eur J Nucl Med Mol Imaging May 2004; 31(5): 655-662. (Pubitemid 38647903)
21. Romanens M, Goerre S, Zellweger M, M P. Long-term coronary risk in relation to exercise test, Sestamibi myocardial perfusion, lung uptake, transient ischaemic dilation and left ventricular volumes. Kardiovaskulare Medezin 2009; 12(4): 114-121.
22. Yang MF, Dou KF, Liu XJ, Yang YJ, He ZX. Prognostic value of normal exercise 99mTc-Sestamibi myocardial tomography in patients with angiographic coronary artery disease. Nucl Med Commun Apr 2006; 27(4): 333-338.